Edition:
United Kingdom

Aixtron SE (AIXGn.DE)

AIXGn.DE on Xetra

9.75EUR
21 Sep 2018
Change (% chg)

€-0.23 (-2.31%)
Prev Close
€9.98
Open
€10.00
Day's High
€10.03
Day's Low
€9.48
Volume
2,226,876
Avg. Vol
1,056,126
52-wk High
€19.75
52-wk Low
€9.48

Latest Key Developments (Source: Significant Developments)

Aixtron Raises Order Intake Guidance After Q2 Results
Thursday, 26 Jul 2018 

July 26 (Reuters) - Aixtron SE ::RAISES 2018 ORDER INTAKE GUIDANCE TO 260-290 MILLION EUR FROM 230-260 MILLION.NOW SEES 2018 SALES AT 260 MILLION EUR (VERSUS 230-260 MILLION), GROSS MARGIN 40 PERCENT (VERSUS 35-40 PERCENT), EBIT MARGIN 10 PERCENT (VERSUS 5-10 PERCENT).Q2 ORDER INTAKE 75.6 MILLION EUROS, DOWN 4 PERCENT VERSUS Q1, VERSUS REUTERS POLL AVERAGE 74.7 MILLION.Q2 SALES 55.2 MILLION EUROS, DOWN 12 PERCENT VERSUS Q1, VERSUS REUTERS POLL AVERAGE 60.2 MILLION.Q2 EBIT 4.1 MILLION EUROS, DOWN 48 PERCENT, VERSUS REUTERS POLL AVERAGE 4.2 MILLION.Q2 NET PROFIT 3.7 MILLION EUROS, DOWN 70 PERCENT VERSUS Q1.  Full Article

‍Committee on Foreign Investment in the U.S. approves Aixtron's sale of ALD/CVD memory product line
Tuesday, 24 Oct 2017 

Oct 23 (Reuters) - Aixtron Se :‍CFIUS approves sale of ALD/CVD memory product line / closing expected in 2017​.Investigation resulted in determination that there are no unresolved U.S. National security concerns from CFIUS' perspective​ for deal.‍CFIUS approved transaction​.  Full Article

Aixtron: ‍Kim Schindelhauer to resume his position as chairman of supervisory board​
Thursday, 8 Jun 2017 

June 8 (Reuters) - AIXTRON SE ::DR. FELIX GRAWERT APPOINTED AS A NEW MEMBER OF THE EXECUTIVE BOARD / DR. GRAWERT TO ASSUME HIS POSITION ON OCTOBER 1, 2017 OR EARLIER / DR. SCHULTE AND DR. GRAWERT TO JOINTLY LEAD THE COMPANY .‍KIM SCHINDELHAUER TO RESUME HIS POSITION AS CHAIRMAN OF SUPERVISORY BOARD​.  Full Article

Aixtron to sell its ALD/CVD memory product line
Thursday, 25 May 2017 

May 25 (Reuters) - AIXTRON SE ::AIXTRON SE TO SELL ITS ALD/CVD MEMORY PRODUCT LINE / THE TRANSACTION IS SUBJECT TO REGULATORY APPROVALS / THE TRANSACTION IS EXPECTED TO CLOSE IN THE SECOND HALF OF 2017.AGREED PURCHASE PRICE IN A RANGE BETWEEN USD 45 MILLION AND USD 55 MILLION WILL BE PAID IN CASH AT CLOSING.TO SELL ALD AND CVD MEMORY PRODUCT LINE, AT AIXTRON, INC. BASED IN SUNNYVALE, CALIFORNIA TO EUGENE TECHNOLOGY INC., A WHOLLY OWNED U.S. SUBSIDIARY OF EUGENE TECHNOLOGY CO., LTD, SOUTH KOREA.EXPECTS THAT THIS TRANSACTION WILL NOT AFFECT FULL YEAR 2017 GUIDANCE WITH ORDER INTAKE AND REVENUES BETWEEN EUR 180 AND 210 MILLION.GUIDANCE INCLUDES CORE BUSINESS AND ALD/CVD BUSINESS UP TO DATE OF SALE.  Full Article

GCI offer for Aixtron crosses acceptance hurdle
Friday, 14 Oct 2016 

Grand Chip Investment : Says acceptance rate of Aixtron SE takeover offer at 59.97 percent, above minimum threshold of 50.1 percent Further company coverage: [AIXGn.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

German stocks - Factors to watch on September 6

BERLIN, Sept 6 The following are some of the factors that may move German stocks on Thursday: